{"id":"NCT02338843","sponsor":"La Jolla Pharmaceutical Company","briefTitle":"A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension","officialTitle":"A Phase 3, Placebo-Controlled, Randomized, Double-Blind, Multi-Center Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension (CRH)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2016-12-01","completion":"2017-02-18","firstPosted":"2015-01-14","resultsPosted":"2018-01-17","lastUpdate":"2018-03-27"},"enrollment":344,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Catecholamine-resistant Hypotension (CRH)","Distributive Shock","High Output Shock","Sepsis"],"interventions":[{"type":"DRUG","name":"LJPC-501","otherNames":["angiotensin II"]},{"type":"DRUG","name":"Placebo","otherNames":["0.9% Sodium Chloride Solution USP"]}],"arms":[{"label":"LJPC-501 (angiotensin II)","type":"EXPERIMENTAL"},{"label":"Placebo (0.9% sodium chloride solution)","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, double-blind, randomized study of LJPC-501 (angiotensin II) in adult patients diagnosed with catecholamine-resistant hypotension (CRH) conducted in multiple centers globally.","primaryOutcome":{"measure":"An Increased MAP, Defined as Achievement of a Day 1 MAP at 3 Hours Following the Initiation of Study Drug, of â‰¥ 75 mmHg OR a 10 mmHg Increase in Baseline MAP","timeFrame":"Hour 3","effectByArm":[{"arm":"LJPC-501 (Angiotensin II)","deltaMin":114,"sd":null},{"arm":"Placebo (0.9% Sodium Chloride Solution)","deltaMin":37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":115,"countries":["United States","Australia","Belgium","Canada","Finland","France","Germany","New Zealand","Switzerland","United Kingdom"]},"refs":{"pmids":["39972379","38637829","38103056","37147690","32609011","32028998","30144016","28528561","26931475"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":99,"n":163},"commonTop":["Atrial fibrillation","Thrombocytopenia","Hypokalaemia","Anaemia","Hypotension"]}}